Abstract:The lung microbiome plays a crucial role in respiratory health, and its dysbiosis has been associated with lung cancer. This study investigated the relationship between microbiota dysbiosis and immune profiles within the tumor microenvironment (TME) in non‐small cell lung cancer (NSCLC) patients. Metagenomic sequencing was performed on tumor and normal tissues from 61 NSCLC patients and six patients with other lung diseases. Cytokine concentrations were measured in 24 lung tumor and normal tissues using a multiple cytokine panel. The results showed lower microbiota diversity in tumors compared to paired normal tissues, with enrichment of Proteobacteria, Firmicutes, and Actinobacteria in NSCLC. Proinflammatory cytokines, including IL‐8, MIF, and TNF‐α, were significantly upregulated in tumor tissues. Specific bacteria were linked to host inflammatory signaling pathways and immune cells. Dysbiosis in the lower airway microbiome may disrupt the equilibrium of the immune system and contribute to lung inflammation and the spread of lung cancer. Background The lung has a sophisticated microbiome, and respiratory illnesses are greatly influenced by the lung microbiota. Despite the fact that numerous studies have shown that lung cancer patients have a dysbiosis as compared to healthy people, more research is needed to explore the association between the microbiota dysbiosis and immune profile within the tumor microenvironment (TME). Methods In this study, we performed metagenomic sequencing of tumor and normal tissues from 61 non‐small cell lung cancer (NSCLC) patients and six patients with other lung diseases. In order to characterize the impact of the microbes in TME, the cytokine concentrations of 24 lung tumor and normal tissues were detected using a multiple cytokine panel. Results Our results showed that tumors had lower microbiota diversity than the paired normal tissues, and the microbiota of NSCLC was enriched in Proteobacteria, Firmicutes, and Actinobacteria. In addition, proinflammatory cytokines such as IL‐8, MIF, TNF‐ α, and so on, were significantly upregulated in tumor tissues. Conclusion We discovered a subset of bacteria linked to host inflammatory signaling pathways and, more precisely, to particular immune cells. We determined that lower airway microbiome dysbiosis may be linked to the disruption of the equilibrium of the immune system causing lung inflammation. The spread of lung cancer may be linked to specific bacteria.

Lung cancer shapes commensal bacteria via exosome-like nanoparticles

Spatial meta-transcriptomics reveal intratumor bacterial association with lung cancer cells showing a distinct oncogenic signature.

Special tissue microbiota such as Cyanobacteria are associated with the immune microenvironment of lung adenocarcinoma

Role of Respiratory System Microbiota in Development of Lung Cancer and Clinical Application

Convergent alteration of lung tissue microbiota and tumor cells in lung cancer

Alterations of lower respiratory tract microbiome and short-chain fatty acids in different segments in lung cancer: a multiomics analysis

Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer

Symbiotic microbial communities in various locations of the lung cancer respiratory tract along with potential host immunological processes affected

The crosstalk of intratumor bacteria and the tumor

Host-Microbiome Interaction in Lung Cancer

Unveiling microbial dynamics in lung adenocarcinoma and adjacent nontumor tissues: insights from nicotine exposure and diverse clinical stages via nanopore sequencing technology

Microbiota Modulate Tumoral Immune Surveillance in Lung Through a Γδt17 Immune Cell-Dependent Mechanism.

Microbiome Related Cytotoxically Active CD8+ TIL Are Inversely Associated With Lung Cancer Development

Dysregulation of NK and CD8+T Cells by the Microbiota Promotes the Progression of Lung Cancer

Dysbiosis of lower respiratory tract microbiome are associated with proinflammatory states in non‐small cell lung cancer patients

The airway microbiota of non‐small cell lung cancer patients and its relationship to tumor stage and EGFR gene mutation

Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature

Characterization of the lung microbiome and exploration of potential bacterial biomarkers for lung cancer

The lung, the niche, and the microbe: Exploring the lung microbiome in cancer and immunity

Pulmonary microbiota signatures adjacent to adenocarcinoma, squamous cell carcinoma and benign lesion

Gram-negative Bacteria Facilitate Tumor Outgrowth and Metastasis by Promoting Lipid Synthesis in Lung Cancer Patients.